Victory Capital Management
NXTM

Victory Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Victory Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,091,649
Closed -$27.4M – 1907
2017
Q2 		$27.4M Sell
1,091,649
-322,450
-23% -$7.98M 0.06% 488
2017
Q1 		$37.9M Buy
1,414,099
+89,830
+7% +$2.48M 0.09% 375
2016
Q4 		$34.7M Sell
1,324,269
-465,070
-26% -$11.5M 0.09% 399
2016
Q3 		$44.7M Buy
+1,789,339
New +$41.7M 0.13% 275

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Victory Capital Management's NXTM Position: Q3 2017 in Review

Victory Capital Management sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 1,091,649 shares — an estimated $27.4M sold.

Victory Capital Management first reported a position in NXTM in Q3 2016 and held it in 4 quarters. The position peaked at $44.7M in Q3 2016. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Victory Capital Management reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Victory Capital Management sold 1,091,649 NxStage Medical Inc. shares in Q3 2017, an estimated $27.4M.
  • Victory Capital Management first reported a position in NxStage Medical Inc. in Q3 2016 and held it in 4 quarters.
  • Victory Capital Management's NxStage Medical Inc. position peaked at $44.7M in Q3 2016.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Victory Capital Management's 13F filing for Q3 2017, filed 27 Oct 2017.